VitiligoVision is an innovative research initiative led by the Department of Dermatology and Allergy at the University Hospital rechts der Isar, Technical University of Munich. The study explores the use of high-resolution whole-body imaging and telemedicine to improve the early detection, diagnosis, and longitudinal monitoring of vitiligo, a chronic skin condition associated with depigmentation and significant psychosocial burden.

The project leverages digital outreach and search data analysis to identify individuals actively researching skin changes—such as “white patches”—online. Participants are invited to undergo a standardized, non-invasive full-body scan, which is remotely assessed by board-certified dermatologists. In cases of suspected vitiligo, clinical confirmation and guideline-based care are provided.

By integrating cutting-edge imaging technology with teledermatology, VitiligoVision aims to shorten diagnostic delays, support personalized disease monitoring, and evaluate patient acceptance of digital care models. In addition to quantitative analysis, qualitative interviews explore patient experiences and barriers in the digital care journey. The long-term goal is to scale this approach beyond vitiligo and extend access to advanced dermatologic diagnostics across underserved regions.